Watchlist Price Alert

Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · Real-Time Price · USD

24.74

-0.52 (-2.06%)

At close: May 13, 2025, 3:59 PM

Summit Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jan 31, 2019	Jan 31, 2018	Jan 31, 2017
Cash & Equivalents	104.86M	71.42M	348.61M	71.79M	66.42M	49.96M	35.23M	28.45M	35.08M
Short-Term Investments	307.49M	114.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.55M	5.28M	577K	170K	21.26M	3.27M	n/a	-0.00	n/a
Receivables	557K	848K	349K	1.46M	10.19M	5.29M	n/a	11.09M	n/a
Inventory	n/a	n/a	301.5M	7.16M	-11.71M	1.56	n/a	n/a	110.56K
Other Current Assets	10.84M	181K	300.49M	1.2M	1.52M	6.86M	16.25M	15.78M	4.59M
Total Current Assets	423.75M	189.71M	656.71M	97.31M	66.42M	62.11M	61.29M	50.8M	41.67M
Property-Plant & Equipment	7.4M	6.06M	5.08M	3.48M	1.28M	1.2M	807.92K	1.15M	144.99K
Goodwill & Intangibles	1.86M	1.89M	1.8M	12.41M	13.54M	8.87M	16.29M	24.44M	5.17M
Total Long-Term Assets	11.81M	13.24M	7.46M	16.06M	36.08M	13.34M	17.09M	25.58M	5.31M
Total Assets	435.56M	202.95M	664.17M	113.37M	102.5M	75.46M	78.39M	76.38M	46.98M
Account Payables	4.64M	2.67M	355K	4.37M	6.14M	2.63M	5.8M	12.49M	1.13M
Deferred Revenue	n/a	n/a	n/a	7.94M	8.37M	1.17M	n/a	-18.03M	8.64M
Short-Term Debt	3.77M	n/a	19.77M	284.24K	n/a	632.64K	n/a	n/a	n/a
Other Current Liabilities	33.33M	9.5M	6.3M	5.31M	1.71M	2.45M	10.62M	20.04M	6.64M
Total Current Liabilities	41.73M	20.41M	38.78M	25.62M	19.89M	9.9M	16.88M	26.81M	13.62M
Long-Term Debt	n/a	100M	494.54M	n/a	n/a	n/a	n/a	-17.21M	n/a
Other Long-Term Liabilities	5.08M	1.56M	1.43M	3.22M	2.51M	2.2M	3.28M	5.73M	-39.87K
Total Long-Term Liabilities	5.08M	104.85M	498.73M	4.47M	3.15M	4.44M	5.71M	35.59M	37.73M
Total Liabilities	46.81M	125.26M	537.51M	30.09M	23.05M	14.34M	22.59M	62.4M	51.35M
Total Debt	7.22M	106.1M	518.76M	2.78M	465K	699.64K	n/a	n/a	n/a
Common Stock	7.38M	7.02M	2.11M	980K	826K	3.47M	2.1M	1.04M	772.47K
Retained Earnings	-1.21B	-993.26M	-378.33M	-299.55M	-214.74M	-97.61M	-99.8M	-114.51M	-92.21M
Comprehensive Income	-2.29M	-2.45M	-1.89M	-2.2M	-3.79M	22.03M	n/a	n/a	25.74M
Shareholders Equity	388.75M	77.69M	126.65M	83.28M	79.45M	61.12M	55.8M	13.98M	-4.37M
Total Investments	307.49M	114.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a